# OnCo record paper-tap-lancet (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-tap-lancet/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-tap-lancet" ;
  schema:name "Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial"@en ;
  schema:description "Paper cited by one cancer page, one trial page, one treatment page and one target page, indexed on Europe PMC as PubMed record 31229240 and published in The Lancet; the citing pages link this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-tap-lancet/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s0140-6736(19)30764-0>, <https://pubmed.ncbi.nlm.nih.gov/31229240/>, <https://europepmc.org/article/MED/31229240> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s0140-6736(19)30764-0> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Tap WD, Gelderblom H, Palmerini E, et al." ;
  onco:related <https://onco.cc/cancers/tenosynovial-giant-cell-tumour/>, <https://onco.cc/drugs/pexidartinib/>, <https://onco.cc/targets/csf1r/> ;
  onco:trials <https://onco.cc/trials/enliven/> ;
  onco:journals <https://onco.cc/journals/lancet/> .